NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/10/2020
Back to search
Official data from USPTO
OROPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OROPHARMA
ST13
US500000077703890Class
5, 31
Filing
77703890
Registration
3721400
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
01/10/2020
Trademark type
Word
Nice classes
5, 31
Filing date
04/01/2009
Registration date
12/08/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/10/2020
Last transaction
01/10/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Deinze, BE
Examiner
FICKES, JERI
Law office
L70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Oropharma, naamloze vennootschap
Representatives
Martin W. Schiffmiller KIRSCHSTEIN ISRAEL SCHIFFMILLER & PIERONI, P.C.
Technical classification
Nice Classes
Class 5Class 31
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparations and substances for treatment of infections and parasitic diseases in poultryminor species and small animals; food for infants and food for medically restricted diets; dietetic food productsfood and nutritional supplementsdiet pillsdietary drink mix for use as meal replacement; animal feed additive for use as dietary supplements; vitamins
Class 31
Animal foodstuffs; non-medicated nutritional additives for livestock feed
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/10/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/10/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/10/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
11/21/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/08/2018
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
01/07/2016
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
01/07/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/07/2016
ES8R
TEAS SECTION 8 RECEIVED
12/07/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
12/08/2009
PUBO
PUBLISHED FOR OPPOSITION
09/22/2009
NPUB
NOTICE OF PUBLICATION
09/02/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/17/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/13/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
08/13/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/13/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
08/13/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/13/2009
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
08/13/2009
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
08/10/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/28/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/25/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
07/25/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/25/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
07/25/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/25/2009
DMCC
DATA MODIFICATION COMPLETED
07/21/2009
ALIE
ASSIGNED TO LIE
07/21/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/25/2009
GNRT
NON-FINAL ACTION E-MAILED
06/25/2009
CNRT
NON-FINAL ACTION WRITTEN
06/25/2009
DOCK
ASSIGNED TO EXAMINER
06/20/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/06/2009
NWAP
NEW APPLICATION ENTERED
04/04/2009
Continuous trademark protection
Get notified about every new filing that threatens OROPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.